87.10
전일 마감가:
$87.60
열려 있는:
$87.685
하루 거래량:
8.68M
Relative Volume:
1.15
시가총액:
$111.40B
수익:
$407.94B
순이익/손실:
$2.90B
주가수익비율:
38.25
EPS:
2.2771
순현금흐름:
$7.39B
1주 성능:
-7.82%
1개월 성능:
-6.36%
6개월 성능:
+21.85%
1년 성능:
+15.93%
CVS헬스 Stock (CVS) Company Profile
명칭
Cvs Health Corp
전화
(401) 765-1500
주소
ONE CVS DR., WOONSOCKET
Compare CVS vs UNH, ELV, CI, HUM
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
CVS
Cvs Health Corp
|
87.10 | 121.07B | 407.94B | 2.90B | 7.39B | 2.2771 |
|
UNH
Unitedhealth Group Inc
|
372.95 | 340.27B | 450.13B | 14.91B | 23.62B | 15.55 |
|
ELV
Elevance Health Inc
|
402.43 | 90.81B | 201.11B | 4.95B | 6.29B | 22.50 |
|
CI
Cigna Group
|
273.74 | 74.19B | 278.13B | 6.74B | 7.66B | 23.60 |
|
HUM
Humana Inc
|
372.00 | 49.21B | 137.20B | 1.15B | 1.27B | 9.3439 |
CVS헬스 Stock (CVS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-03-12 | 업그레이드 | Bernstein | Mkt Perform → Outperform |
| 2025-10-14 | 개시 | Goldman | Buy |
| 2025-08-18 | 업그레이드 | UBS | Neutral → Buy |
| 2025-08-14 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2025-02-13 | 업그레이드 | Leerink Partners | Market Perform → Outperform |
| 2025-02-12 | 업그레이드 | Cantor Fitzgerald | Neutral → Overweight |
| 2025-01-30 | 업그레이드 | Edward Jones | Hold → Buy |
| 2024-12-03 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2024-11-18 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2024-10-10 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2024-10-04 | 업그레이드 | TD Cowen | Hold → Buy |
| 2024-05-30 | 개시 | Robert W. Baird | Neutral |
| 2024-05-07 | 다운그레이드 | TD Cowen | Buy → Hold |
| 2024-05-02 | 다운그레이드 | UBS | Buy → Neutral |
| 2024-05-01 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2024-05-01 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2024-03-06 | 개시 | Barclays | Equal Weight |
| 2024-02-26 | 개시 | Leerink Partners | Outperform |
| 2023-12-22 | 개시 | HSBC Securities | Buy |
| 2023-09-19 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2023-09-12 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2023-08-18 | 다운그레이드 | Edward Jones | Buy → Hold |
| 2023-05-26 | 개시 | Piper Sandler | Overweight |
| 2023-04-21 | 개시 | Cantor Fitzgerald | Overweight |
| 2023-01-03 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2022-11-23 | 재개 | Morgan Stanley | Overweight |
| 2022-06-17 | 개시 | Loop Capital | Buy |
| 2022-05-27 | 다운그레이드 | Bernstein | Outperform → Mkt Perform |
| 2022-03-29 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2022-02-11 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2021-12-14 | 개시 | Goldman | Buy |
| 2021-12-01 | 개시 | Seaport Research Partners | Buy |
| 2021-05-19 | 개시 | Wells Fargo | Equal Weight |
| 2021-03-17 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2021-01-08 | 업그레이드 | Jefferies | Hold → Buy |
| 2020-09-17 | 개시 | Piper Sandler | Overweight |
| 2020-07-01 | 개시 | SVB Leerink | Mkt Perform |
| 2020-05-14 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2019-09-27 | 재개 | RBC Capital Mkts | Outperform |
| 2019-09-12 | 개시 | Deutsche Bank | Buy |
| 2019-06-05 | 업그레이드 | Standpoint Research | Hold → Buy |
| 2019-04-29 | 다운그레이드 | Credit Suisse | Outperform → Neutral |
| 2019-04-18 | 개시 | Guggenheim | Buy |
| 2019-04-15 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2019-04-10 | 재확인 | BofA/Merrill | Buy |
| 2019-03-13 | 개시 | Bernstein | Outperform |
| 2019-02-20 | 다운그레이드 | Wells Fargo | Outperform → Market Perform |
| 2019-01-17 | 개시 | UBS | Buy |
| 2018-12-18 | 개시 | Barclays | Overweight |
| 2018-11-29 | 재개 | Goldman | Neutral |
| 2018-11-28 | 개시 | Evercore ISI | Outperform |
| 2018-10-26 | 재개 | Wolfe Research | Peer Perform |
| 2018-07-09 | 업그레이드 | Citigroup | Neutral → Buy |
| 2018-02-27 | 재개 | BofA/Merrill | Buy |
| 2018-02-13 | 재확인 | Citigroup | Neutral |
모두보기
CVS헬스 주식(CVS)의 최신 뉴스
Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks Delivering High-Dividend Yields - benzinga.com
CVS Health stock holds near USD 87.73 as earnings beat estimates - AD HOC NEWS
CVS Health stock closes lower at the close - AD HOC NEWS
State Street Corp Boosts Stake in CVS Health Corporation $CVS - MarketBeat
Value-based care is hard, but it’s worth getting right - CVS Health
UBS reiterates CVS Health stock rating citing no new surprises - Investing.com
CVS Health stock trades at USD 87.60 as guidance rises - AD HOC NEWS
CVS Health (NYSE:CVS) Faces Healthcare Execution As Defensive Sectors Draw - Kalkine Media
CVS Health’s Yield Touched 3% as the Stock Slid. Is the Payout a Bargain or a Warning? - Yahoo Finance
CVS Health (CVS) Stock Declines While Market Improves: Some Information for Investors - Yahoo Finance
CVS Health Corp. stock underperforms Monday when compared to competitors - MarketWatch
Judge approves bankruptcy plan for CVS’ Omnicare - Modern Healthcare
Here's What Might Affect CVS Health's 2026 Financial Outlook - Barchart.com
CVS Health Corp stock gains analyst support as oncology initiative advances - AD HOC NEWS
Top 3 Health Care Stocks That May Rocket Higher In September - benzinga.com
Judge approves CVS unit Omnicare’s bankruptcy plan - Yahoo Finance
CVS Health Corp. stock gains on strong earnings and analyst upgrade - AD HOC NEWS
CVS Health (NYSE:CVS) Raised to "Strong-Buy" at Wall Street Zen - MarketBeat
CVS Health Corp (NY: CVS - The Chronicle-Journal
What’s Really Driving the CVS Health (NYSE:CVS) Value Stocks Story? - Kalkine Media
CVS Health Corp. stock underperforms Friday when compared to competitors - MarketWatch
Should You Buy CVS Stock For The Margin Aetna Is Rebuilding? - Trefis
CVS Health Corp. stock edges lower as valuation questions grow after Omnicare sale and cancer care e - AD HOC NEWS
CVS Health Corp. stock underperforms Thursday when compared to competitors - MarketWatch
CVS Unit Omnicare Bankruptcy Plan Approved After Sale, DOJ Deal - news.bloomberglaw.com
CVS Health's Aetna Aims To Reduce Admin Tasks For Cancer CareCVS Health (NYSE:CVS) - benzinga.com
Aetna expands oncology prior authorization bundles - CVS Health
CVS Health Corp. stock underperforms Wednesday when compared to competitors - MarketWatch
CVS Health launches national "Wear Your HeART" Bandage Art Contest - CVS Health
Four artists could win $5,000 and see their art on CVS bandages - Stock Titan
What Does CVS Health (CVS) Updated COVID Vaccine Rollout Mean For Patients? - Yahoo Finance
CVS Health Corp. stock outperforms competitors despite losses on the day - MarketWatch
Healthy aging starts with understanding your whole health: A Q&A with Dr. Heidi Schwarzwald - CVS Health
Here's How CVS' Health Services Arm Is Positioned for Long-Term Growth - Yahoo Finance
CVS Health Corporation $CVS Shares Sold by Corient Private Wealth LP - MarketBeat
CVS Health Corporation $CVS Stake Increased by The Manufacturers Life Insurance Company - MarketBeat
Engineers Gate Manager LP Reduces Position in CVS Health Corporation $CVS - MarketBeat
CVS Health (NYSE:CVS) Cut to Buy at Wall Street Zen - MarketBeat
CVS Renews Bid To Escape Investors' AI Use Suit - Law360
CVS Health Corp. stock gains analyst support as Overweight rating and higher targets reinforce recov - ad-hoc-news.de
What is moving CVS Health (NYSE:CVS) shares in today's market? - Kalkine Media
Cantor Fitzgerald reiterates CVS Health stock rating on Stars outlook - investing.com
CVS Health Corporation $CVS Shares Bought by Tidal Investments LLC - MarketBeat
NewEdge Advisors LLC Purchases 51,116 Shares of CVS Health Corporation $CVS - MarketBeat
Allworth Financial LP Cuts Stock Holdings in CVS Health Corporation $CVS - MarketBeat
CVS Health Corporation (NYSE:CVS) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Building a culture of support at CVS Health Corp. - Providence Business News
CVS Health stock heads into the open after a modest September 10 gain - ad-hoc-news.de
Is CVS Health (CVS) Still Undervalued After Its Wells Fargo Healthcare Conference Update? - simplywall.st
CVS Health stock holds gains after UBS cuts target - ad-hoc-news.de
Should You Buy, Hold or Sell CVS Stock Amid Consumer Wellness Growth? - Yahoo Finance
CVS헬스 (CVS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
CVS헬스 주식 (CVS) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| ROBBINS LARRY | Director |
May 19 '26 |
Sale |
94.45 |
1,983,538 |
187,341,308 |
6,213,261 |
| ROBBINS LARRY | Director |
May 20 '26 |
Sale |
93.82 |
1,018,000 |
95,510,822 |
5,195,261 |
| ROBBINS LARRY | Director |
May 21 '26 |
Sale |
93.45 |
370,462 |
34,619,007 |
4,824,799 |
자본화:
|
볼륨(24시간):